LDA-SVM-Based EGFR Mutation Model for NSCLC Brain Metastases


Epidermal growth factor receptor (EGFR) activating mutations are a predictor of tyrosine kinase inhibitor effectiveness in the treatment of non-small-cell lung cancer (NSCLC). The objective of this study is to build a model for predicting the EGFR mutation status of brain metastasis in patients with NSCLC. Observation and model set-up. This study was… (More)
DOI: 10.1097/MD.0000000000000375


7 Figures and Tables

Cite this paper

@inproceedings{Hu2015LDASVMBasedEM, title={LDA-SVM-Based EGFR Mutation Model for NSCLC Brain Metastases}, author={Nan Hu and Ge Wang and Yu-Hao Wu and Shi-Feng Chen and Guo-Dong Liu and Chuan Chen and Dong Qing Wang and Zhong-shi He and Xue-Qin Yang and Yong He and Hua-liang Xiao and Ding-de Huang and Kun-lin Xiong and Yan Wu and Ming Huang and Zhen-zhou Yang and Leonardo Roever.}, booktitle={Medicine}, year={2015} }